Sort by

Send to

Choose Destination

Search results

Items: 11


Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infection.

Iuliano AD, Feingold E, Wahed AS, Kleiner DE, Belle SH, Conjeevaram HS, Zmuda J, Liang TJ, Yee LJ; Virahep-C Study..

Intervirology. 2009;52(1):49-56. doi: 10.1159/000214380.


Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.

Yee LJ, Im K, Borg B, Yang H, Liang TJ; Virahep-C Study..

Genes Immun. 2009 Jun;10(4):365-72. doi: 10.1038/gene.2009.26.


Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.

Terrault NA, Im K, Boylan R, Bacchetti P, Kleiner DE, Fontana RJ, Hoofnagle JH, Belle SH; VIRAHEP-C Study Group..

Clin Gastroenterol Hepatol. 2008 Dec;6(12):1403-11. doi: 10.1016/j.cgh.2008.08.006.


Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.

Yee LJ, Im K, Wahed AS, Bugawan T, Li J, Rhodes SL, Erlich H, Rosen HR, Liang TJ, Yang H; Virahep-C Study..

Antimicrob Agents Chemother. 2009 Feb;53(2):615-21. doi: 10.1128/AAC.00947-08.


Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy.

Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH.

J Virol. 2007 Apr;81(7):3391-401.


Differential gene induction by type I and type II interferons and their combination.

Sanda C, Weitzel P, Tsukahara T, Schaley J, Edenberg HJ, Stephens MA, McClintick JN, Blatt LM, Li L, Brodsky L, Taylor MW.

J Interferon Cytokine Res. 2006 Jul;26(7):462-72.


Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro.

Taylor MW, Grosse WM, Schaley JE, Sanda C, Wu X, Chien SC, Smith F, Wu TG, Stephens M, Ferris MW, McClintick JN, Jerome RE, Edenberg HJ.

J Interferon Cytokine Res. 2004 Feb;24(2):107-18.


The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.

O'Connor RJ, Schaley JE, Feeney G, Hearing P.

Oncogene. 2001 Apr 5;20(15):1882-91.


Induction of the cellular E2F-1 promoter by the adenovirus E4-6/7 protein.

Schaley J, O'Connor RJ, Taylor LJ, Bar-Sagi D, Hearing P.

J Virol. 2000 Mar;74(5):2084-93.


Modulation of APRT transcription by altering spacing between cis-regulatory elements.

She BR, Schaley JE, Taylor MW.

Somat Cell Mol Genet. 1995 Jan;21(1):43-50.

Items per page

Supplemental Content

Loading ...
Support Center